Predicting Early Outcomes of Prostatic Artery Embolization Using n-Butyl Cyanoacrylate Liquid Embolic Agent: A Machine Learning Study
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: A TabPFN model predicted 7-week symptom-score response after prostatic-artery embolization in 109 retrospective patients (AUROC 0.821) under repeated internal cross-validation; this is a narrow short-term prediction result, not evidence of treatment benefit or external validity.
Technology: TabPFN learns from clinical and procedural features to classify six-week IPSS response
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- TabPFN learns from clinical and procedural features to classify six-week IPSS response
- Limitation / still unknown
- The findings are limited to the reported dataset, experimental setup and validation described in the source; broader generalization and real-world benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/40506923 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12154727/ · https://pubmed.ncbi.nlm.nih.gov/40506923/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.